Reaction of pyridoxamine with malondialdehyde: Mechanism of inhibition of formation of advanced lipoxidation end-products

Amino Acids

Volumn 30, Issue 1, 2006, Pages 55-61

  Kang, Z ^a   Li, H ^a   Li, G ^a   Yin, D ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Advanced glycation end products (AGEs); Advanced lipoxidation end products (ALEs); Carbonyl stress; Malondialdehyde (MDA); Pyridoxamine (PM)

Indexed keywords

ACROLEIN DERIVATIVE; ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; CARBONYL DERIVATIVE; DIHYDROPYRIDINE DERIVATIVE; LIPOFUSCIN; MALONALDEHYDE; PYRIDINIUM DERIVATIVE; PYRIDOXAMINE;

ARTICLE; FLUORESCENCE; GLYCATION; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; PYRIDOXAMINE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

BOVINAE;

EID: 32944455107     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-005-0209-6     Document Type: Article

References (31)

1. NL Alderson ME Chachich NN Youssef RJ Beattie M Nachtigal SR Thorpe JW Baynes 2003 The AGEs inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats. Kidney Int 63 2123 2133
2. V Amarnath K Amarnath K Amarnath S Davies LJ Roberts 2004 Pyridoxamine: an extremely potent scavenger of 1,4-dicarbonyls. Chem Res Toxicol 17 410 415
3. JW Baynes SR Thorpe 2000 Glycation and lipoxidation in atherogensis. Free Radic Biol Med 28 1708 1716
4. GJ Brealey M Kasha 1955 The role of hydrogen bonding in the n → π* blue-shift phenomenon. J Am Chem Soc 77 4462 4468
5. M Brownlee 1995 Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46 223 234
6. KS Chio AL Tapple 1969 Synthesis and characterization of the fluorescent products derived from malondialdehyde and amino acids. Biochemistry 8 2821 2832
7. CA Colaco CR Harrington 1994 Glycation: a pathological modification in neuropathies? a hypothesis. Neuroreport 5 859 861
8. TP Degenhardt NL Alderson DD Arrington RJ Beattie JM Basgen MW Steffes SR Thorpe JW Baynes 2002 Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int 61 939 950
9. H Esterbauer RJ Schaur H Zollner 1991 Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 11 81 128
10. K Itakura K Uchida 2001 Evidence that malondialdehyde-derived aminoenimine is not a fluorescent age pigment. Chem Res Toxicol 14 473 475
11. K Itakura K Uchida T Osawa 1996 A novel fluorescent malondialdehyde- lysine adduct. Chem Phys Lipids 84 75 79
12. K Kikugawa K Tsukuda T Kurechi 1980 Studies on peroxidized lipids. 1. Interaction of malondialdehyde with secondary amine and its relevance to nitrosamine formation. Chem Pharm Bull 28 3323 3331
13. K Kikugawa Y Machida M Kida T Kurechi 1981 Studies on peroxidized lipids. III. Fluorescent pigments derived from the reaction of malondialdehyde and amino acids. Chem Pharm Bull 29 3003 3011
14. RG Khalifah JW Baynes BG Hudson 1999 Amadorins: novel post-amadori inhibitors of advanced glycation reactions. Biochem Biophys Res Commun 257 251 258
15. WR Markesberry 1995 Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23 134 147
16. TO Metz NL Alderson SR Thorpe JW Baynes 2003 Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications. Arch Biochem Biophys 419 41 49
17. T Miyata K Kurokawa C Van Ypersele De Strihou 2000 Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J Am Soc Nephrol 11 1744 1752
18. T Miyata C Van Ypersele de Strihou K Kurokawa JW Baynes 1999 Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 55 389 399
19. RH Nagaraj P Sarkar A Mally KM Biemel MO Lederer PS Padayatti 2002 Effect of Pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of PM and methylglyoxal. Arch Biochem Biophys 402 110 119
20. LJ Niedernhofer JS Daniels CA Rouzer RE Greene LJ Marnett 2003 Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem 278 31426 31433
21. JM Onorato AJ Jenkins SR Thorpe JW Baynes 2000 Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. J Biol Chem 275 21177 21184
22. HK Shapiro 1998 Carbonyl-trapping therapeutic strategies. Am J Ther 5 323 353
23. DA Slatter M Murray AJ Bailey 1998 Formation of a dihydropyridine derivative as a potential cross-link derived from malondialdehyde in physiological systems. FEBS Lett 421 180 184
24. DA Slatter CH Bolton AJ Bailey 2000 The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 43 550 557
25. A Stitt TA Gardiner NL Anderson P Canning N Frizzell N Duffy C Boyle AS Januszewski M Chachich JW Baynes SR Thorpe 2002 The AGEs inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51 2826 2832
26. SR Thorpe JW Baynes 1996 Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging 9 69 77
27. PA Voziyan RG Khalifah C Thibaudeau A Yildiz J Jacob AS Serianni BG Hudson 2003 Modification of proteins in vitro by physiological levels of glucose: Pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions. J Biol Chem 278 46616 46624
28. PA Voziyan TO Metz JW Baynes BG Hudson 2002 A post-Amadori inhibitor Pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem 277 3397 3403
29. H Wang LJ Marnett TM Harris CJ Rizzo 2004 A novel synthesis of malondialdehyde adducts of deoxyguanosine, deoxyadenosine, and deoxycytidine. Chem Res Toxicol 17 144 149
30. D Yin 1995 Studies on age pigments evolving into a new theory of biological aging. Gerontology 41 [Suppl 2] 159 172
31. D Yin 1996 Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radic Biol Med 21 871 888